Allergan 410 Implant Recall: A Comprehensive Guide
In recent years, the medical industry has witnessed a significant recall of Allergan's Biocell textured breast implants, specifically the Natrelle 410 implants. This article aims to provide a comprehensive, SEO-optimized, and human-like overview of the Allergan 410 implant recall, its causes, impacts, and what patients should know.
Understanding the Allergan 410 Implant Recall
The Allergan 410 implant recall, also known as the Biocell textured implant recall, was initiated in July 2019 by the U.S. Food and Drug Administration (FDA). The recall was prompted by an increased risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare type of cancer that can develop following breast implants.
What are Textured Breast Implants?
Textured breast implants, like the Allergan 410, have a rough surface designed to help them stay in place and reduce the risk of movement or rotation. However, these textured surfaces can also harbor bacteria, leading to inflammation and, in rare cases, BIA-ALCL.

Causes of the Allergan 410 Implant Recall
The primary cause of the Allergan 410 implant recall was the increased risk of BIA-ALCL associated with the Biocell textured surface. As of July 2019, the FDA had received 573 unique BIA-ALCL cases worldwide and 481 of these were attributed to Allergan Biocell textured implants.
Risk Factors
- Implant Type: Allergan Biocell textured implants were found to have a higher risk of BIA-ALCL compared to other textured and smooth implants.
- Implant Size: Larger implants may have a higher risk of BIA-ALCL.
- Implant Placement: Implants placed above the muscle may have a higher risk of BIA-ALCL.
Impacts of the Allergan 410 Implant Recall
The Allergan 410 implant recall has had significant impacts on both patients and the medical industry. Here are some key impacts:
- Patient Safety: The recall has raised awareness about the potential risks associated with textured breast implants, leading to more informed decision-making among patients.
- Medical Industry: The recall has prompted a review of other textured breast implants and led to changes in manufacturing processes and surgical techniques.
- Legal Implications: The recall has led to numerous lawsuits against Allergan, with patients alleging that the company failed to adequately warn about the risks of their implants.
What Patients Should Know
If you have Allergan Biocell textured implants, it's essential to stay informed and take the following steps:

- Consult your healthcare provider to discuss your individual risk and the best course of action.
- Be aware of any changes in your breasts, such as pain, swelling, or lumps, and report these to your healthcare provider immediately.
- Keep all follow-up appointments with your healthcare provider and maintain open communication about your concerns and questions.
Alternatives to Allergan 410 Implants
Since the recall, many patients have been seeking alternatives to Allergan Biocell textured implants. Smooth implants, which have a lower risk of BIA-ALCL, have become more popular. Additionally, some patients may opt for fat transfer procedures as an alternative to implants.
It's crucial to consult with a qualified healthcare provider to discuss the best options for your individual needs and circumstances.